Skip to content

Real-world study of polydocaanol injection in hemorrhoid disease: a multicenter, prospective study

Real-world study of polydocaanol injection in hemorrhoid disease: a multicenter, prospective study

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073657
Enrollment
Unknown
Registered
2023-07-18
Start date
2023-07-15
Completion date
Unknown
Last updated
2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoid disease

Interventions

polydoccaalcohol in treating hemorrhoids experimental group :None

Sponsors

The Sixth Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age: 18 years old; 2.Patients diagnosed with internal hemorrhoids or mixed hemorrhoids according to the Chinese Guidelines for diagnosis and Treatment of Hemorrhoid Disease (2020); 3.Patients who can be evaluated with polydochaper alone or in combination; 4.Signed signed informed consent and followed protocol requirements.

Exclusion criteria

Exclusion criteria: 1. Patients diagnosed with external hemorrhoids; 2. Patients who are allergic to any component of polydocanol or polydocanol hardener; 3. Patients with severe systemic diseases (especially untreated); 4. Patients with acute inflammatory reactions (anal infection, abscess) or anal fissure in the anal area; 5. Heating state; 6. Bronchial asthma or known allergic constitution; 7. Severe important organ diseases or autoimmune dysfunction; 8. Chronic inflammatory bowel disease (such as Crohn's disease); 9. Patients with known hypercoagulable state; 10. Pregnant women, lactating women, or those who are unable to use contraception during the study period; 11. Individuals with a history of mental illness or neurological dysfunction; 12. Other situations where the researcher deems it unsuitable to participate in the study.

Design outcomes

Primary

MeasureTime frame
Anal scope examination results ;

Secondary

MeasureTime frame
Bleeding score ;Hemorrhoid prolapse score ;The Itch / Pain Visual Analogue Scale score;Hemorrhoid Symptoms Scale Scale score;The European Five-Dimensional Health Scale score;Patient satisfaction;recurrence;

Countries

China

Contacts

Public ContactRen Donglin

The Sixth Affiliated Hospital of Sun Yat-sen University

rendl@mail.sysu.edu.cn+86 136 0000 1818

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026